Their findings, published in the May 20, 2015 issue of Science Translational Medicine, could open the door to an entirely new class of medications that specifically prevents joint damage and brings relief to patients who don't respond to
available treatment regimes.
To prove that this is a true deprivation, it must be shown that the expediency and scope of the services
available under the WCA to injured workers are greater than those services publicly
available; the fact that alternative
treatment options are
available does not diminish the deprivation faced by agricultural workers facing longer delays to get
treatment outside of the WCA
regime.